Chong‐Hui Gu - Concepedia

Author

Chong‐Hui Gu

Bristol-Myers Squibb (United States)

Also Known As

Chong-Hui Gu, Chonghui Gu, Chong‐Hui Gu

Publications

954

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)

About

Chong‐Hui Gu is an author at Bristol-Myers Squibb (United States) specializing in engineering, chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	3	3	602
2	Medicine	3	3	613
3	Biomolecular Engineering	2	2	480
4	Public Health	1	1	153
5	Biostatistics	1	1	153

Chong‐Hui Gu

Publications

925

Citations

H-Index

Page 1

	Year	Citations
Grouping solvents by statistical analysis of solvent property parameters: implication to polymorph screening Chong‐Hui Gu, Hua Li, Rajesh Gandhi, International Journal of Pharmaceutics EngineeringPolymer SolutionChemometricsMacromolecular SystemOrganic Chemistry	2004	438
Predicting Effect of Food on Extent of Drug Absorption Based on Physicochemical Properties Chong‐Hui Gu, Hua Li, Jaquan K. Levons, Pharmaceutical Research NutritionPhysicochemical PropertiesMedicineFood AnalysisChemometric Method	2007	153
Using a Novel Multicompartment Dissolution System to Predict the Effect of Gastric pH on the Oral Absorption of Weak Bases with Poor Intrinsic Solubility Chong‐Hui Gu, Deepa Rao, Rajesh Gandhi, Journal of Pharmaceutical Sciences Solvent ExtractionGastric PhPoor Intrinsic SolubilityWeak BasesAnalytical Chemistry	2004	132
Crystallization and Transitions of Sulfamerazine Polymorphs Geoff G. Z. Zhang, Chong‐Hui Gu, Mark T. Zell, Journal of Pharmaceutical Sciences Materials ScienceEngineeringPolymer ScienceSulfamerazine PolymorphsChemistry	2002	122
Polymorph screening: Influence of solvents on the rate of solvent‐mediated polymorphic transformation Chong‐Hui Gu, Victor G. Young, David Grant Journal of Pharmaceutical Sciences Synthetic MacromoleculeEngineeringPolymer SciencePolymorphic TransformationMacromolecular System	2001	42
Importance of using physiologically relevant volume of dissolution medium to correlate the oral exposure of formulations of BMS-480188 mesylate Chong‐Hui Gu, Rajesh Gandhi, Lee K. Tay, International Journal of Pharmaceutics Dissolution MediumPharmacologyBms-480188 MesylateToxicologyOral Exposure	2003	22
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent Cancers Rishi G. Vaswani, David S. Huang, Neville J. Anthony, Journal of Medicinal Chemistry	2025	16

Page 1